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Abstract: Cyanobacteria are photosynthetic prokaryotes found in a range of environments. 
They are infamous for the production of toxins, as well as bioactive compounds, which 
exhibit anticancer, antimicrobial and protease inhibition activities. Cyanobacteria produce 
a broad range of antifungals belonging to structural classes, such as peptides, polyketides 
and alkaloids. Here, we tested cyanobacteria from a wide variety of environments for 
antifungal activity. The potent antifungal macrolide scytophycin was detected in Anabaena 
sp. HAN21/1, Anabaena cf. cylindrica PH133, Nostoc sp. HAN11/1 and Scytonema sp. 
HAN3/2. To our knowledge, this is the first description of Anabaena strains that produce 
scytophycins. We detected antifungal glycolipopeptide hassallidin production in Anabaena 
spp. BIR JV1 and HAN7/1 and in Nostoc spp. 6sf Calc and CENA 219. These strains  
were isolated from brackish and freshwater samples collected in Brazil, the Czech 
Republic and Finland. In addition, three cyanobacterial strains, Fischerella sp. CENA 298, 
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Scytonema hofmanni PCC 7110 and Nostoc sp. N107.3, produced unidentified antifungal  
compounds that warrant further characterization. Interestingly, all of the strains shown to 
produce antifungal compounds in this study belong to Nostocales or Stigonematales  
cyanobacterial orders. 
Keywords: natural products; drug leads; Candida albicans; Aspergillus sp.; 16S rRNA 
 
1. Introduction 
Cyanobacteria are photosynthetic cosmopolitan prokaryotic organisms that have been isolated from 
aquatic (freshwater, brackish and marine), terrestrial (soil, lichen-associated and the surface of leaves), 
and different aquatic and terrestrial extreme environments (hot springs, high salinity, deserts) [1,2]. In 
these environments, cyanobacteria face competitors and predators, including parasitic fungi, such as 
chytrids. The production of oligopeptides by Planktothrix spp. is believed to contribute to the defense 
against chytrid fungi [3,4]. Antifungal compounds have been previously detected in cyanobacterial 
extracts, such as fischerellin A, hapalindole, hassallidin/balticidins, carazostatin, phytoalexin, tolytoxin, 
scytophycin, toyocamycin, tjipanazole, nostocyclamide, nostodione and nostofungicidine [5–7]. Most of 
these compounds are synthetized by ribosomal pathways or by nonribosomal pathways. Examples of 
enzymes involved in the nonribosomal pathways are nonribosomal peptide synthetase (NRPS), 
polyketides synthases (PKS) or hybrid systems of both NRPS/PKS. The NRPSs and PKSs are 
multifunction modular enzymes involved in the synthesis of nonribosomal peptides and  
polyketides [8,9]. In cyanobacteria, the antifungal hassallidin is synthesized by NRPSs and tailoring 
enzymes [10]. Interestingly, a single hassallidin gene cluster encoded in the biosynthetic pathway for 
more than 40 chemical variants of hassallidin in Anabaena sp. SYKE748A [10]. 
Invasive fungal infections caused by Candida spp. and Aspergillus spp. are common, especially in 
immunocompromised patients. The increase of antifungal resistance indicates an urgent need for new 
antifungal compounds [11–13]. Here, we screened cyanobacteria for antifungal compounds, and we 
were able to detect known, but also potential new antifungal natural products. 
2. Results and Discussion 
2.1. Cyanobacteria Producing Antifungal Compounds 
We screened 194 cyanobacterial strains isolated from brackish water, freshwater and terrestrial 
habitats using a disc diffusion assay (Table 1, Supplementary Table S1). Freeze-dried cells of 
cyanobacteria were extracted with methanol and were tested by the disc diffusion assay against 
Candida albicans and/or Aspergillus flavus. Ten strains were found to produce bioactive compounds 
inhibiting Candida albicans and nine inhibiting Aspergillus flavus (Table 1, Supplementary Figure S1). 
These eleven strains with antifungal compounds were analyzed using LC-MS. 
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Table 1. Cyanobacterial strains producing antifungal compounds according to the disc 
diffusion assay. 
Cyanobacteria 
16S rRNA 
Gene 
Origin 
Inhibited 
Organism(s) 
Antifungal 
Compound 
Nostoc sp. CENA 219 KP701037 Benthic freshwater, Brazil Ca/Af hassallidin 
Anabaena sp. BIR JV1 KP701036 The Gulf of Finland Ca hassallidin 
Anabaena sp. HAN7/1 KP701033 Epilithic, Finland Ca hassallidin 
Nostoc calcicula 6 sf Calc KP701034 Dobre Pole, Czech Republic Ca/Af hassallidin 
Anabaena sp. HAN21/1 KP701032 Gastropod, Finland Ca/Af scytophycin 
Anabaena cf. cylindrica PH133 AJ293110 Lake Arresø, Denmark Ca/Af scytophycin 
Scytonema sp. HAN3/2 KP701039 Green biofilm in the pond, Finland Ca/Af scytophycin 
Nostoc sp. HAN11/1 KP701035 Small pond on a rock, Finland Ca/Af scytophycin 
Fischerella sp. CENA 298 KP701038 Soil, Brazil Ca/Af unidentified 
Scytonema hofmanni PCC 7110 NR112180 Limestone, Bermuda Ca/Af unidentified 
Nostoc sp. N107.3 KP701040 Lichen, Finland Af unidentified 
Ca = Candida albicans; Af = Aspergillus flavus. 
Antifungal compounds in Anabaena sp. HAN21/1, Anabaena cf. cylindrica PH133, Nostoc sp. 
HAN11/1 and Scytonema sp. HAN3/2 were identified to be scytophycins (Sc) with LC-MS. The 
identification based on the molecular masses of the compounds showed losses of multiple 32-Da 
neutral fragments (typical for aliphatic methoxy groups containing compounds). In addition, the  
15N-labeling experiments of Anabaena sp. HAN21/1 showed that these compounds contained a single 
nitrogen atom (Supplementary Figure S2). To confirm the identity of these compounds, the main 
antifungal compound of Anabaena sp. HAN21/1 was isolated by HPLC. NMR analysis 
(Supplementary Figures S3 and S4 and Table S2) showed that this compound was 7-OMe-Sc-B (1, 
Figure 1). The NMR sample contained also another compound scytophycin analog 2, the structure of 
which can be derived from 7-OMe-Sc-B via the photocatalytic Paternò–Büchi reaction (Figure 1). This 
7-OMe-Sc-B preparation presented a MIC/IC50 of 0.33/0.16 mg·mL−1 (0.40/0.19 mM) for Candida 
albicans HAMBI 484 and 0.67/0.29 mg·mL−1 (0.80/0.23 mM) for Candida guilliermondii HAMBI 257. 
Several scytophycin variants were identified from strains Anabaena sp. HAN21/1, Anabaena cf. 
cylindrica PH133, Nostoc sp. HAN11/1 and Scytonema sp. HAN3/2 (Figure 2, Table 2 and 
Supplementary Table S3). These strains produced known and previously unreported scytophycins 
variants (Table 2 and Supplementary Table S3 and S4), and their identification was based on the 
existence of prominent [M + Na]+ and also often [M + H − H2O]+ ions with masses at the range of 
reported scytophycins (Supplementary Figure S2) and of the characteristic product ion spectra of 
[M + Na]+ (example spectrum from 7-OMe-Sc-B in Supplementary Figure S5). Detailed mass 
spectrometric structural analysis turned out to be challenging. Protonated dehydrated scytophycins 
generated product ion spectra full of ions for which many represent the loss of water and methanol  
(32 Da), and hence, they were of small value for the determination of the structure (Supplementary 
Figure S6). Nitrogen labeling confirmed that the even number product ions contained the nitrogen 
atom of the scytophycins (Supplementary Figures S6 and S7). Product ion spectra from sodiated 
scytophycins were more structurally informative, showing fewer product ions, as seen from the spectrum 
of sodiated 7-OMe-Sc-B (Supplementary Figure S5). Nitrogen labeling again confirmed the presence of 
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nitrogen in the product ions (Supplementary Figure S7). The base peaks in the scytophycin product ion 
spectra (for example, m/z 620 from 7-OMe-Sc-B) and ion m/z 262 contained nitrogen (Supplementary 
Figure S7). Based on the aforementioned data, the tentative fragmentation and structure of 33 scytophycins 
are presented in Supplementary Tables S3 and S5. 
 
Figure 1. 7-OMe-scytophycin-B (1) isolated from Anabaena sp. HAN21/1 and  
7-OMe-scytophycin-B reacted by light (2) after the Paternò–Büchi reaction. 
Stereochemistry is according to the literature. 
 
Figure 2. Total ion current chromatograms of methanol extracts of Scytonema sp. 
HAN3/2, Nostoc sp. HAN11/1, Anabaena sp. HAN21/1 and Anabaena cf. cylindrica 
PH133 showing the elution of scytophycin variants 1–33. Bolded numbers and arrows 
show the main scytophycin variants. 
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Table 2. Scytophycin variants, retention times (Rt), experimental (Exp) and calculated (Cal) [M + Na]+ ion masses (m/z), mass error in ppm 
(∆), formula and abundance (+, ++, +++), in the studied Scytonema sp. HAN3/2, Nostoc sp. HAN11/1, Anabaena sp. HAN21/1 and Anabaena 
cf. cylindrica PH133 strains. a Mass from [M + H − H2O]+, because [M + Na]+ was absent. New variants are indicated by “N” and in bold. 
      
Strains 
Scytophycin (Sc) variant 
Rt (min) 
[M + Na]+ (m/z) 
 
 
HAN3/2 HAN11/1 HAN21/1 PH133 
No. Chemical variant Exp Cal ∆ (ppm) Formula 
10 N 6-OH-7-OMe-15-O-deMe-Sc-B 19.9 858.5 
    
++ 
  
15 6-OH-7-OMe-Sc-D/E 20.1 874.5 
    
++ 
  
16 N X-OH-Sc-D/E (not 6-OH) 20.3 860.5116 860.5131 −1.70 C45H75NO13 ++ 
 
+ ++ 
18 Sc-D/E 20.6 844.5157 844.5181 −2.90 C45H75NO12 ++ 
 
+ ++ 
19 N Sc 20.6 814.5a 
    
++ 
  
20 6-OH-7-OMe-Sc-B 20.6 872.5 
    
+++ + 
 
22 N Sc 20.9 842.5 
   
++ 
 
+ 
 
25 Sc-B 21.3 842.5022 842.5025 −0.35 C45H73NO12 +++ ++ ++ +++ 
26 N Sc, (-O from C15/16/17/19) 21.9 826.5062 826.5076 −1.67 C45H73NO11 ++ + + ++ 
27 Sc-C 22.4 828.5221 828.5232 −1.37 C45H75NO11 ++ ++ + ++ 
29 N 7-OMe-29-OAc-Sc-B 22.6 884.5129 884.5131 −0.18 C47H75NO13 
  
++ 
 
30 7-OMe-Sc-B (1) 23.5 856.5 
   
+ + +++ +++ 
31 N 7-OMe-Sc, (-O from C15/16/17) 24.0 840.5 
    
+ ++ + 
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Fourteen variants of hassallidin (Figure 3) were detected in the Nostoc sp. CENA 219 methanol 
extract (Figure 4, Table 3). The hassallidin variants differ in the presence of sugars (pentose, 
deoxyhexose, hexose, acetylated hexose and N-acetylhexosamine), by the composition of the 
aglyconic peptide core structure and the fatty acid moiety (Table 3). The relative amounts of 
hassallidin variants can be roughly estimated from the TIC chromatograms presented in Figure 4. 
Variants 11, 15 and 26 are the most abundant hassallidins in Nostoc sp. CENA 219. They all have the 
same aglyconic lipopeptide structure m/z 1298 but the number of monosaccharides differs.  
N-acetylhexosamine was found only from the Brazilian Nostoc sp. CENA 219. Ten variants of 
hassallidins were detected in the Nostoc calcicula 6 sf Calc, nine variants from the Anabaena sp. BIR 
JV1 and Anabaena sp. HAN7/1 methanol extract (Figure 4, Table 3 and Supplementary Figures S9–S15). 
The main hassallidin variants found in the extract of Nostoc calcicula 6 sf Calc were 12, 14 and 15. 
The hassallidin 12 was also detected in the Anabaena spp. BIR JV1 and HAN7/1 and the hassallidin 
15 in the Nostoc sp. CENA 219 cells extracts. Variants 12, 13 and 16 were the most abundant 
hassallidins in Anabaena sp. BIR JV1 and Anabaena sp. HAN7/1, respectively. They have the same 
aglyconic lipopeptide structure m/z 1,298 but the degree of acetylation on hexose in the position M3 
varies (Figure 3). Altogether, hassallidin profiles of Anabaena sp. BIR JV1 and Anabaena sp. HAN7/1 
were highly similar. The structure of the aglyconic lipopeptide m/z 1298 is unknown. The hassallidin 
structures have been deduced from the mass spectra presented in the Supplementary Figures S9–S15. 
 
Figure 3. The general chemical structure of hassallidin. M1–M3 are monosaccharides, R1 is 
the hydrocarbon chain of the fatty acid chain FA1 and R2–R10 side chains of amino acids Aa2  
to Aa10. 
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Figure 4. Total ion current chromatograms of methanol extracts of Nostoc sp. CENA 219, 
Nostoc calcicula 6 sf Calc, Anabaena sp. HAN7/1 and Anabaena sp. BIR JV1 showing the 
elution of hassallidin variants 1–27. 
Table 3. Retention times (Rt), ion masses and monosaccharide (M1, M2 and M3) content 
of hassallidin variants in Nostoc sp. CENA 219, Nostoc calcicula 6 sf Calc, Anabaena sp. 
HAN7/1 and Anabaena sp. BIR JV1 strains. The major variants produced are highlighted  
in grey. 
       
Strains 
 
Rt Ion masses (m/z) Monosaccharides 
CENA 219 6sf Calc HAN7/1 BIR JV1 
No (min) AL [M + H]+ [M + Na]+ M1 M2 M3 
1 3.1 1296.6 1815.8 HexNAc Pent Hex x 
   
2 3.5 1294.8 1813.7 HexNAc Pent Hex x 
   
3 5.9 1280.7 1799.8 HexNAc Pent Hex x 
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Table 3. Cont. 
4 6.2 1280.7 1772.8 Hex dHex Hex 
 
x x x 
5 6.5 1278.6 1797.8 HexNAc Pent Hex x 
   
6 6.8 1280.7 1814.9 Hex dHex AcHex 
   
x 
7 7.2 1314.7 1833.7 HexNAc Pent Hex x 
   
8 11.9 1270.7 1789.7 HexNAc Pent Hex x 
   
9 13.7 1236.7 1728.8 Hex dHex Hex 
  
x x 
10 17.7 1282.7 1801.9 HexNAc Pent Hex x 
   
11 18.3 1298.7 1817.8 HexNAc Pent Hex x 
   
12 18.4 1298.7 1790.6 Hex dHex Hex 
 
x x x 
13 18.8 1298.7 1832.8 Hex dHex AcHex 
  
x x 
14 18.9 1298.7 1790.8 Hex dHex Hex 
 
x 
  
15 19.3 1298.6 1614.7 
 
Pent Hex x x 
  
16 19.6 1298.7 1874.8 Hex dHex diAcHex 
  
x x 
17 20.2 1264.7 1783.9 HexNAc Pent Hex x 
   
18 20.3 1264.7 1756.6 Hex dHex Hex 
  
x x 
19 20.5 1298.7 1628.7 
 
dHex Hex 
 
x 
  
20 20.9 1264.7 1756.8 Hex dHex Hex 
 
x 
  
21 21.0 1298.7 1916.8 Hex dHex triAcHex 
  
x x 
22 21.4 1264.7 1580.8 
 
Pent Hex x x 
  
23 22.5 1280.6 1958.7 Hex dHex tetraAcHex 
  
x x 
24 22.7 1266.7 1785.8 HexNAc Pent Hex x 
   
25 22.7 1298.7 1452.7 
 
Pent 
  
x 
  
26 23.9 1298.7 1482.7 
  
Hex x x 
  
27 26.3 1264.7 1448.7     Hex x x x   
AL = Aglyconic lipopeptide containing substructures FA1 and Aa2–Aa10, HexNAc = N-acetylhexosamine (residue 
mass 203 Da), Pent = pentose (132), dHex = deoxyhexose (146), Hex = hexose (162), tetra/tri/di/AcHex = tetra-, 
tri-, di- or monoacetylhexose (330, 288, 246, 204). 
The methanol extract of Scytonema hofmanni PCC 7110 was fractionated by HPLC and tested 
against Aspergillus flavus. However, the bioactivity was lost during the re-isolation of the fraction 
containing the antifungal compound. 
2.2. Evolutionary Relation of the Cyanobacterial Strains Producing Antifungal Compounds 
A phylogenetic tree was constructed based on partial 16S rRNA gene sequences of the 
cyanobacteria producing antifungal compounds and other strains retrieved from the NCBI database 
(Figure 5). Analyzing the Anabaena sp. HAN21/1 16S rRNA gene sequence similarity of 99% with 
Anabaena cf. cylindrica PH133 in GenBank (NCBI) compelled us to check if this strain could produce 
scytophycin. Interestingly, through the phylogenetic analysis, we found another Anabaena strain 
isolated from a different environment producing scytophycins. 
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Figure 5. The distribution of cyanobacterial strains producing antifungal compounds. The 
neighbor-joining phylogenetic tree is based on the 16S rRNA genes sequences constructed 
with 1000 bootstraps in which the percentages over 50 are indicated in each node. Studied 
strains are in bold. 
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2.3. Discussion 
The screening for antifungal compounds produced by cyanobacteria led us to discover new strains 
producing scytophycins and hassallidins. Antifungal compounds were detected from strains belonging 
to the Nostocales and Stigonematales orders, such as Anabaena, Fischerella, Nostoc and Scytonema. 
Phylogenetic analysis based on 16S rRNA gene sequences shows that the studied strains are widely 
distributed in the tree (Figure 5). It is common to have non-producers and producers of bioactive 
compounds grouped together in phylogenetic trees [14,15]. We first detected Anabaena sp. HAN21/1, 
isolated from a gastropod living in brackish water in the coast of Finland, producing scytophycins. The 
comparison of the 16S rRNA gene sequence of this strain with other sequences in the NCBI led us to 
investigate if the first hit, Anabaena cf. cylindrica PH133, could also produce scytophycin. 
Surprisingly, we detected Anabaena cf. cylindrica PH133, isolated from freshwater of Lake Arresø in 
Denmark producing scytophycins. Interestingly, this is the first report to our knowledge of Anabaena 
strains producing scytophycins. Two other benthic cyanobacteria from the Baltic Sea coast, Nostoc sp. 
HAN11/1 and Scytonema sp. HAN3/2, were also detected to produce scytophycin (Tables 1 and 2). 
The studied strains produced a diverse variety of scytophycin, including scytophycin B, C, D/E 
(Table 2). Scytophycins have been previously reported to be produced by Scytonema spp. [16,17], 
Cylindrospermum [18] and Nostoc sp. 5/96 [19]. Tolytoxin, which was first detected in Tolypothrix 
conglutinata var. colorata, is also known as 6-hydroxy-7-O-methyl-scytophycin B [16,17]. Fourteen 
scytophycin variants have been described by other authors before, in which the six variable positions 
reported are C-6, -7, -16, -19, -23 and -27 (Supplementary Table S4). The main chemical variant 
isolated from Anabaena sp. HAN21/1 was 7-OMe-scytophycin-B, which had been previously reported 
from Nostoc sp. 5/96 [19]. Nitrogen labeling of Anabaena sp. HAN21/1 confirmed the presence of 
nitrogen in the product ions. The base peaks in the scytophycin product ion spectra (for example, m/z 
620 from 7-OMe-Sc-B) and ion m/z 262 contained nitrogen (Supplementary Figure S7). However, the 
product ions structures for ion m/z 262 and m/z 620 reported in Tomsickova et al., 2013, did not 
contain nitrogen, which is missing from the scytophycin structures that they reported. The Scytonema, 
Tolypothrix, Cylindrospermum and Nostoc strains described to produce scytophycins were all isolated 
from terrestrial habitats [18,19]. 
Scytophycins are macrolides polyketides, but the biosynthetic genes involved in their synthesis  
are unknown. Other compounds that have been described to be structurally related to scytophycins are 
lobophorolide [20], swinholides, aplyronine, sphinxolides/reidispongiolides and ulapualides/kabiramide/ 
halichondramides/mycalolides [21]. Aplyronine A, sphinxolide, mycalolide A and ulapualide A have 
very similar side chains to scytophycins, with all presenting an N-methylvinylformamide [21]. 
Interestingly, these compounds have been found in other organism than cyanobacteria: seaweed 
Lobophora variegate, a symbiont in the red sea sponge Theonella swinhoei, sea hare Aplysia kurodai, an 
unidentified nudibranch, marine sponges Neosiphonia superstes and Reidispongia coerulea, egg masses 
of the nudibranch Hexabranchus sanguineas, sponges Halichondria sp. and Mycale spp. and hard coral 
Tubastraea faulkneri [21]. Swinholide A, scytophycins, sphinxolide, ulapualides, mycolides and 
aplyronine A have potent cytotoxicity against cancer cell lines [21]. Interestingly, tolytoxin has been 
proposed to play an ecological role in the defense system of Scytonema ocellatum [22]. The 
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cyanobacteria increased the synthesis of tolytoxin when in the presence of the fungal cell-wall 
polysaccharide chitin [22]. 
We report for the first time to our knowledge a variant of the scytophycin isolated from Anabaena 
sp. HAN21/1, which can be altered after a Paternò–Büchi reaction catalyzed by light (Figure 1). This 
photochemical reaction modifies the side chain and probably was responsible for the loss of activity of 
7-OMe-scytophycin-B. 
Hassallidins are lipopeptides produced by nonribosomal biosynthetic enzymes in  
cyanobacteria [10,23,24]. Hassallidins have been detected previously in Cylindrospermopsis, 
Anabaena, Aphanizomenon, Nostoc, Tolypothrix and Hassalia [10,23,24]. In this study, diverse 
variants of hassallidins were detected in methanol extracts from strains Nostoc spp. 6 sf Calc and 
CENA 219 and Anabaena spp. BIR JV1 and HAN7/1 (Table 3). 
The Nostoc sp. CENA 219 hassallidins’ (Table 3) monosaccharide composition was similar to 
Nostoc sp. 113.5 monosaccharides [10], but the aglyconic lipopeptide structures were more variable in 
the present studied strains. Nostoc calcicula 6 sf Calc hassallidin structures were similar to Nostoc sp. 
159 and Tolypothrix sp. PCC 9009 hassallidin structures (Supplementary Material in [10]). Anabaena 
sp. BIR JV1 and Anabaena sp. HAN7/1 hassallidins (Table 3) monosaccharide composition was 
similar to Anabaena spp. XPORK 5C, XSPORK 7B and BECID 19 monosaccharides [10], but the 
aglyconic lipopeptide structures were more variable in the strains in the present study. The detailed 
aglyconic lipopeptide structure is difficult to analyze reliably from the product ion spectrum of the 
aglyconic lipopeptide ion and could be determined by NMR analysis of purified hassallidin variants. 
Alternatively, the study of the substrate specificities of the adenylation domains of the hassallidin 
genes N, O, V and Y could be used to predict which amino acids are incorporated into the peptide [10]. 
Balticidins belongs to the family of hassallidin compounds, and they have been recently detected in 
Anabaena cylindrica Bio33 [25]. Balticidins are cyclic or linear peptides that differ from hassallidin by 
the presence of arabinose and galacturonic acid and the possible presence of chlorine in the fatty acid 
chain [25]. Hassallidins and balticidins are known for their activity against Candida spp. [10,25,26]. 
Hassallidins A and B were found to be active against Cryptococcus neoformans, Aspergillus spp., 
Fusarium spp., Penicillium sp., Ustilago maydis and Acremonium strictum [26]. In addition, 
hassallidins A and B were active against human acute T-cell leukemia (Jurkat ATCC-TIB-152) and 
murine aneuploid fibrosarcoma (L 929) [26]. Hassallidin D was shown to be a more potent antifungal 
than hassallidin A and B [10]. However, several variants of hassallidins are produced in trace amounts 
by the cyanobacteria, and the heterologous expression or syntheses of these variants is necessary to 
evaluate the activity of these compounds. The high amount of variants of hassallidins discovered 
recently highlights the potential of cyanobacteria for the synthesis of antifungal compounds. There is a 
need for further studies to analyze the potential of these new variants as antifungal and anticancer drugs. 
Our screening study also revealed cyanobacterial strains producing unidentified antifungal 
compounds. Fischerella sp. CENA 298, Scytonema hofmanni PCC 7110 and Nostoc sp. N107.3 
presented antifungal activity. LC-MS analysis of methanol crude extracts and isolated compounds by 
HPLC did not reveal insights into the chemical structure of these antifungal compounds. Further 
analyses are necessary for isolation and characterization of these bioactive compounds. 
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3. Experimental Section 
3.1. Cultivation of Cyanobacterial Strains 
The cyanobacterial strains were cultivated in Z8 medium [27] with or without a nitrogen source, in  
BG-11 [28] with, without or containing half of the amount of nitrogen, AA (Allen and Arnon) medium [29] 
or ASM medium [30]. The strains were cultivated in the specific medium (40–3000 mL) at 17 °C–25 °C 
under continuous light of 3–15 μmol·m−2·s−1. The strain Anabaena sp. HAN21/1 was labeled with 15N 
and analyzed with LC/MS, as previously described [31]. 
3.2. Extraction of Intracellular Cyanobacterial Compounds 
The cells analyzed were obtained either from a 40-mL culture centrifuged at 8000× g for 5 min or 
from freeze-dried biomass (up to 100 mg). The fresh culture cells from the 40 mL of medium were 
extracted with 1 mL of methanol and glass beads (0.5-mm diameter glass beads, Scientific Industries 
INC) using a FastPrep cell disrupter instrument three times for 30 s at a speed of 6.5 m·s−1. The 
samples were centrifuged for 10,000× g for 5 min at room temperature and kept in a glass tube. The 
cells were extracted a second time using another 1 mL of methanol, as described before, and both 
methanol extracts were combined and dried with a stream of air. Residues were re-suspended in  
200 μL of methanol, sonicated (Sonorex super 10P, Bandelin, Berlin, Germany) and kept at −20 °C for 
further analysis. A total of 100 mg of the freeze-dried biomass were extracted two times with 1 mL of 
methanol, as described before. The obtained supernatant was reserved for further analysis. 
3.3. Disc Diffusion Assay 
Methanol extracts (100–400 μL) from all of the studied strains were applied to a paper disc (Abtek 
Biologicals Ltd., Liverpool, United Kingdom). Candida albicans HAMBI261 was grown in yeast and 
mold agar (YM) medium, while Candida albicans HAMBI484 and Aspergillus flavus HAMBI 829 
were grown in potato dextrose agar (PDA) medium. The inoculum for the bioassay was prepared as 
previously described [10]. The discs containing crude extract were applied on the PDA or YM media 
plates containing Candida albicans HAMBI 261 or HAMBI 484 and/or Aspergillus flavus HAMBI 
829. After a period of 24 h for yeast at 35 °C or 48 h at 28 °C for mold, the plates were analyzed for 
inhibition zones, which were measured including the paper disk diameter. 
3.4. Chemical Analysis 
The obtained methanol extracts that contained antifungal activity were studied by LC-MS (Agilent 
1100 Series LC/MSD Trap XCT Plus, Agilent Technologies, Palo Alto, CA, USA). All samples were 
analyzed with the following protocol: Luna C8(2) column (150 × 4.60 mm, 5 μm, 100 Å, Phenomenex, 
Torrance, CA, USA) with two eluents (A: 0.1% HCOOH in water, Fluka, Sigma-Aldrich (St. Louis, 
MO, USA); and B: 2-propanol in 0.1% HCOOH, Optima® LC/MS quality, Fischer Scientific, Fair 
Lawn, NJ, USA), used in a linear gradient, where Eluent B increased from 5% to 100% in 35 min with 
flow rate of 0.15 mL·min−1 and an injection volume of 10 μL. The mass spectrometer trap drive value 
was 144.0 with a scan range of m/z 200–1100. Samples suggesting signs of hassallidins were  
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re-analyzed with the following protocol: Luna C18(2) column with 0.1% HCOOH in water or 
acetonitrile was used in the linear gradient, where the concentration of the acetonitrile eluent was 
increased from 30% to 70% in 49 min with a flow rate of 0.15 mL·min−1 and an injection volume of 10 μL. 
The mass spectrometer trap drive value was 110 with a scan range of m/z 300–2200. These obtained 
UV-, MS- and MS2-product ion spectrums were analyzed. 
3.5. Purification of Scytophycin 
HPLC (HP 1100 Series, Agilent, with DAD) was used to isolate the main scytophycin variant from 
the methanol extract of strain Anabaena sp. HAN21/1. The methanol extract was evaporated to 
dryness, and the residue was dissolved in HPLC eluent (40% isopropanol, 60% 0.1% HCOOH; 700 μL 
of eluent to every 1 mL of methanol extract), which was then injected in 100-μL batches into the Luna 
C8(2) column (150 × 4.60 mm, 5 μm, 100 Å, Phenomenex, Torrance, CA, USA). The column was 
eluted isocratically with a flow rate of 0.75 mL·min−1. Peaks eluting at 13.5 min were collected and 
combined in one tube. The eluent was evaporated, and the residue was dissolved in methanol, which was 
applied to the SP column (Phenomenex Strata C18-E 55 μm, 70 Å, 5 g/20 mL Giga Tubes, Torrance, CA 
USA), eluted with methanol. Dried and [D6] DMSO-dissolved compound was analyzed with NMR. 
3.6. NMR of Scytophycin 
The NMR spectra of 7-OMe-scytophycin-B derivative (Figure 1, compound 2) were recorded on 
the Varian Inova 600 spectrometer equipped with a cryogenically-cooled 1H/13C/15N triple resonance 
probe head and an actively-shielded z-axis gradient system in [D6] DMSO at 301 K. The 1H spectrum 
was measured with 8 transients using 24,000 complex points, which corresponds to an acquisition time 
of 2 s. Two-dimensional homonuclear total correlation spectroscopy (TOCSY) and double-quantum 
filtered correlation spectroscopy (DQF-COSY) experiments were both measured with 8 transients per 
FID (free induction decay), using 300 and 2386 complex points in the t1 and t2 domains, which 
translates to acquisition times of 43 and 341 ms in the t1 and t2 domains. The 13C-1H heteronuclear 
single quantum coherence (HSQC) spectrum was acquired with 180 and 596 complex points in t1 (13C) 
and t2 (1H), using 16 transients per FID, corresponding to acquisition times of 6 and 85 ms in the 13C 
and 1H dimensions, respectively. The 13C heteronuclear multiple bond correlation (13C-HMBC) 
experiment was measured using 256 and 2380 complex points in t1 (13C) and t2 (1H). This corresponds 
to acquisition times of 7.1 and 340 ms in the 13C and 1H dimensions, respectively. The signals were 
accumulated with 128 transients. The long-range 1H-13C delay was set to optimize transfer for 6 Hz 
1H-13C couplings. 
3.7. Microdilution Assay of Scytophycin 
The microdilution assay was performed against Candida albicans HAMBI484 and Candida 
guilliermondii HAMBI 257, as previously described [10]. The calculation for the minimum inhibitory 
concentration (MIC) and half maximum inhibitory concentration (IC50) is explained in detail in [10]. 
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3.8. DNA Extraction, Sequencing and Phylogenetic Analysis 
The DNA extraction of the strains containing antifungal compounds was obtained using the DNeasy 
Plant Mini Kit (Qiagen Gmbh, Hilden, Germany) or the E.Z.N.A SP Plant DNA Mini Kit (Omega  
Bio-Tek Inc., Norcross, GA, USA). The cells were homogenized in the FastPrep cell disrupter for 30 s 
at 6.5 ms−1 (repeated three times), then the DNA extraction was followed as described in the 
manufacturer’s instructions. The partial 16S rRNA gene was amplified by PCR, as previously 
described [15]. The fragments were cloned into a pCR®2.1-TOPO® vector (Invitrogen, Carslbad, CA, 
USA) and transformed to One Shot® Chemically Competent Escherichia coli TOP10 cells, as 
recommended by the manufacturer. Positive clones were found through PCR using the vector primers 
(M13F and M13R) and sequenced. The phylogenetic tree using the neighbor-joining method was 
obtained in MEGA 5.0 [32]. The Kimura 2-parameter model with 1000 bootstrap replications and 
gamma distributed rates among sites has been used to obtain the phylogenetic tree. 
4. Conclusions 
Cyanobacterial strains were detected producing the antifungal compounds scytophycins and 
hassallidins. In this study, we first described to our knowledge Anabaena spp. producing scytophycins. 
There is a huge potential for the discovery of new variants of known antifungal compounds 
(scytophycins and hassallidins) but also for potential new compounds produced by Fischerella sp. 
CENA 298, Scytonema hofmanni PCC 7110 and Nostoc sp. N107.3 which need to be further analyzed. 
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